Potassium Bromate Enhances N-Ethyl-N-Hydroxyethylnitrosamine–Induced Kidney Carcinogenesis Only at High Doses in Wistar Rats: Indication of the Existence of an Enhancement Threshold
暂无分享,去创建一个
S. Fukushima | Masahiko Kushida | H. Wanibuchi | K. Morimura | M. Wei | Kenichiro Doi | Takashi Yamaguchi | M. Kitano | A. Kakehashi | Al-Salmy Hamoud
[1] S. Fukushima,et al. Lack of mutagenic and toxic effects of low dose potassium bromate on kidneys in the Big Blue rat. , 2008, Mutation research.
[2] A. Deangelo,et al. Kidney Toxicogenomics of Chronic Potassium Bromate Exposure in F344 Male Rats , 2006, Translational oncogenomics.
[3] K. Kanki,et al. In vivo mutagenicity and initiation following oxidative DNA lesion in the kidneys of rats given potassium bromate , 2006, Cancer science.
[4] S. Fukushima,et al. Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide‐induced liver damage in rats , 2006, Cancer science.
[5] T. Umemura,et al. Etiology of bromate-induced cancer and possible modes of action-studies in Japan. , 2006, Toxicology.
[6] Tanya Moore,et al. Molecular biomarkers of oxidative stress associated with bromate carcinogenicity. , 2006, Toxicology.
[7] Tao Chen,et al. Mutagenicity of bromate: implications for cancer risk assessment. , 2006, Toxicology.
[8] S. Fukushima,et al. Existence of No Hepatocarcinogenic Effect Levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without Coadministration with Ethanol , 2006, Toxicologic pathology.
[9] S. Fukushima,et al. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats. , 2006, Cancer letters.
[10] S. Fukushima,et al. Dose‐dependence of promotion of 2‐amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline‐induced rat hepatocarcinogenesis by ethanol: Evidence for a threshold , 2005, Cancer science.
[11] S. Fukushima,et al. Lack of large intestinal carcinogenicity of 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine at low doses in rats initiated with azoxymethane , 2005, International journal of cancer.
[12] T. Ushijima,et al. No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[13] T. Tsukamoto,et al. Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenolimidazo[4,5-b]pyridine. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[14] K. Kanki,et al. Dose‐related changes of oxidative stress and cell proliferation in kidneys of male and female F344 rats exposed to potassium bromate , 2004, Cancer science.
[15] Micheline Kirsch-Volders,et al. Indirect mechanisms of genotoxicity. , 2003, Toxicology letters.
[16] T. Tsukamoto,et al. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. , 2003, Cancer letters.
[17] T. Tsukamoto,et al. Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine , 2002, Japanese journal of cancer research : Gann.
[18] S. Fukushima,et al. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. , 2002, Carcinogenesis.
[19] T. Hirano,et al. Changes in DNA 8-hydroxyguanine levels, 8-hydroxyguanine repair activity, and hOGG1 and hMTH1 mRNA expression in human lung alveolar epithelial cells induced by crocidolite asbestos. , 2001, Carcinogenesis.
[20] M. Yamada,et al. Semi-quantitative evaluation of genotoxic activity of chemical substances and evidence for a biological threshold of genotoxic activity. , 2000, Mutation research.
[21] A Kopp-Schneider,et al. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[22] K M Walsh,et al. Spontaneous neoplasms in control Wistar rats: a comparison of reviews. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[23] N. Konishi,et al. Rodent species and strain difference in kidney and lung pathology induced by N-ethyl-N-hydroxyethylnitrosamine. , 1994 .
[24] S. Richardson,et al. Ozonation Byproducts: Identification of Bromohydrins from the Ozonation of Natural Waters with Enhanced Bromide Levels , 1992 .
[25] M. Takahashi,et al. Toxicity and carcinogenicity of potassium bromate--a new renal carcinogen. , 1990, Environmental health perspectives.
[26] T Sofuni,et al. Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicals. , 1988, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[27] T. Imazawa,et al. Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration. , 1986, Journal of the National Cancer Institute.
[28] T. Imazawa,et al. Dose-related enhancing effect of potassium bromate on renal tumorigenesis in rats initiated with N-ethyl-N-hydroxyethyl-nitrosamine. , 1985, Japanese journal of cancer research : Gann.
[29] T Sofuni,et al. Primary mutagenicity screening of food additives currently used in Japan. , 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[30] S. De Flora. Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity. , 1984, Toxicologic pathology.
[31] M. Ishidate,et al. Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation--a comparative study on mutagens and carcinogens. , 1980, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.